Glaucoma, a leading cause of blindness, demands innovative management strategies. Glaucoma: New therapies and surgical techniques explore minimally invasive glaucoma surgeries (MIGS), such as trabecular meshwork stents, which offer safer alternatives to traditional procedures. Novel pharmacological agents, including rho kinase inhibitors, enhance trabecular outflow, reducing intraocular pressure. Sustained-release drug delivery systems promise improved patient compliance. Diagnostic advancements, like optical coherence tomography angiography, enable earlier detection of optic nerve damage. These developments allow personalized treatment plans, balancing efficacy and safety. Surgeons are adopting laser-based techniques, such as selective laser trabeculoplasty, for precise pressure control. Continuous research and clinical trials are critical to refining these approaches, ensuring better outcomes for patients at risk of vision loss.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : An advanced 3D human-based in vitro model to identify disease-specific molecular markers of glaucoma neurodegeneration
Anna Maria Bassi, University of Genoa, Italy
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom
Title : Evaluating the quality and readability of AI-generated ophthalmic surgery education: A four-model comparison
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom